ARCHIVES

Targeting One Specific Protein Can Double PFS; Triple Overall Survival

This article is from The Cancer Letter archive.

Vol. 34 No. 5 | May 27, 2011

Download PDF Visit The Full Archive

Related Articles

First NCI Director To Resign Due To Presidential Election?

December 15, 2000

Univ. Of Pittsburgh Seeks Senior Prevention Trial Of Tamoxifin should Resume

June 17, 1994

Interview: Burzynski Explains Why He Calls Treatment “Non-Toxic”

September 25, 1998

Director’s Advisory Committee to Make Advice “Kosher”

March 7, 1997

Centers See Trend To Integrate Control Service With Science

February 18, 1983

Avastin Phase III Trial Meets Endpoint: PFS in Platinum-Sensitive Ovarian Cancer

February 25, 2011